An FDA Panel Just Greenlit a Breakthrough Gene Therapy to Cure Blindness

On Thursday, a US Food and Drug Administration review panel gave their stamp of approval to an experimental gene therapy for a rare inherited form of blindness. If ultimately approved by the agency, the technique would be the first gene therapy for an inherited disease approved in the United States--and a landmark in...